Pristyn Care's owned-hospital bet: 8 hospitals by June 2025, 50 planned before FY28 IPO

Pristyn Care runs a surgery-focused healthtech platform selling minimally invasive elective surgeries across specialities — from gynaecology and dermatology to joint replacement and trauma — through partner hospitals and clinics, and since 2025 has been adding its own digitally integrated super-speciality hospitals.

Owning hospitals, not renting partner operating rooms, controls surgical quality and economics — Pristyn bet its capital on a 50-hospital chain ahead of an FY28 IPO.

Founded in 2018 by Harsimarbir Singh, Vaibhav Kapoor and Garima Sawhney, Pristyn Care built an asset-light surgery platform connecting patients with experienced surgeons across partner hospitals and clinics in 50+ cities, claiming more than 2 million patients served and 1.5 lakh surgeries. Revenue rose from ₹452.89 Cr in FY23 to ₹600.52 Cr in FY24, but net losses stayed near ₹381 Cr, and in March 2024 the company cut 120 jobs with an eye on turning profitable in FY25.

In February 2025 Pristyn opened its first owned super-speciality hospital in New Delhi, announcing a shift from asset-light to owned-and-operated care, with plans for 50 hospitals across 25 cities in three years, 3,500 additional healthcare staff and collaboration with more than 750 surgeons. The first Delhi hospital reportedly reached double-digit margins within eight weeks, and in June 2025 three hospitals opened at once in Gurgaon, Hyderabad and Kochi, taking the owned network to eight facilities with 400 beds, 20+ modular operating theatres and 50+ ICU beds, all running on a shared digital backbone of electronic medical records, one-tap insurance approvals and 45-minute automated labs.

Executing a capital-heavy pivot: by August 2026 the company ran nine owned hospitals contributing roughly 35% of revenue, planned to reach 19–20 within 12–18 months, and was demerging its consumer brand BeatXP and scaling back its medical-supplies unit MedX to focus resources on hospitals, with a public listing targeted around FY28.

The asset-light model proved demand but not control: with care in partner hospitals, Pristyn could not own quality, margins or the patient experience — the gap owning hospitals closes.

The digital backbone was the bridge: the same EMR, insurance and lab automation systems built for partner coordination could make each owned hospital operationally consistent from day one.

Early unit economics justified the shift: the first Delhi hospital reportedly reached double-digit margins within eight weeks, giving the 50-hospital plan a template.

The pivot concentrates scarce capital: demerging BeatXP and scaling back MedX shows Pristyn chose depth in hospitals over breadth in consumer health bets ahead of an FY28 listing.

If your promise depends on care quality you don't fully control, asset-light caps you: owning the facility turns a marketplace into a chain with margins, data and an IPO story.

As of September 4, 2026, Pristyn Care was mid-pivot toward owned hospitals: nine facilities contributed ~35% of revenue, 19–20 more were planned within 12–18 months, targeting 50–60% of revenue from owned hospitals. It was demerging BeatXP, scaling back MedX and finalizing a ₹180 Cr Spec Finance (GIFT City) investment. FY25 consolidated revenue was about ₹442 Cr, down from ₹600 Cr in FY24, with losses narrowed to ₹168 Cr; an IPO was targeted around FY28. The main risk: financing a capital-heavy build-out while partner-facility revenue shrank faster than owned hospitals scaled.